These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17000394)

  • 1. Incidence and management of seroma after arteriovenous graft placement.
    Dauria DM; Dyk P; Garvin P
    J Am Coll Surg; 2006 Oct; 203(4):506-11. PubMed ID: 17000394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic grafts.
    Woo K; Doros G; Ng T; Farber A
    J Vasc Surg; 2009 Dec; 50(6):1405-11.e1-2. PubMed ID: 19782518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft.
    Katzman HE; Glickman MH; Schild AF; Fujitani RM; Lawson JH
    J Am Coll Surg; 2005 Aug; 201(2):223-30. PubMed ID: 16038820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of perigraft seroma formation with gelatin-coated polytetrafluoroethylene grafts.
    Ladenheim ED; Lum C; Chadwick N; Agrawal S
    Semin Dial; 2012; 25(6):689-92. PubMed ID: 22686492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistula.
    Lee T; Barker J; Allon M
    J Am Soc Nephrol; 2007 Jun; 18(6):1936-41. PubMed ID: 17475812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patency rates and complications of Exxcel yarn-wrapped polytetrafluoroethylene grafts versus Gore-tex stretch polytetrafluoroethylene grafts: a prospective study.
    Ko PJ; Hsieh HC; Chu JJ; Lin PJ; Liu YH
    Surg Today; 2004; 34(5):409-12. PubMed ID: 15108078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access.
    Slayden GC; Spergel L; Jennings WC
    Semin Dial; 2008; 21(5):474-82. PubMed ID: 18627564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patency rate and complications of vascular access grafts for hemodialysis in lower extremities.
    Salimi J
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):929-32. PubMed ID: 18974578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single center experience in the use of polyurethaneurea arteriovenous grafts.
    Jefic D; Reddy PP; Flynn LM; Provenzano R
    Nephrol News Issues; 2005 Jul; 19(8):44-7. PubMed ID: 16104342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of lower extremity arteriovenous grafts in patients with end-stage renal disease.
    Vogel KM; Martino MA; O'Brien SP; Kerstein MD
    South Med J; 2000 Jun; 93(6):593-5. PubMed ID: 10881776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of infected prosthetic dialysis arteriovenous grafts.
    Ryan SV; Calligaro KD; Scharff J; Dougherty MJ
    J Vasc Surg; 2004 Jan; 39(1):73-8. PubMed ID: 14718819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of hemodialysis access in HIV-positive patients.
    Gorski TF; Gorski YC; Muney J
    Am Surg; 2002 Dec; 68(12):1104-6. PubMed ID: 12516818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of systemic anticoagulation in patients undergoing angioaccess surgery.
    D'Ayala M; Smith RM; Martone C; Briggs W; Deitch JS; Wise L
    Ann Vasc Surg; 2008 Jan; 22(1):11-5. PubMed ID: 18055171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclavian vein to right atrial appendage bypass without sternotomy to maintain arteriovenous access in patients with complete central vein occlusion, a new approach.
    Glass C; Maevsky V; Massey T; Illig K
    Ann Vasc Surg; 2009; 23(4):465-8. PubMed ID: 19359137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of transposed brachiobasilic fistulae with nontransposed fistulae and grafts in the Fistula First era.
    Pflederer TA; Kwok S; Ketel BL; Pilgram T
    Semin Dial; 2008; 21(4):357-63. PubMed ID: 18564963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment for recurrent perigraft seromas of upper arm polytetrafluoroethylene grafts: report of two cases.
    Ko PJ; Liu YH; Chu JJ; Lin PJ
    Chang Gung Med J; 2003 Jun; 26(6):440-3. PubMed ID: 12956291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative placement of MammoSite for breast brachytherapy treatment and seroma incidence.
    Ravi A; Lee S; Karsif K; Osian A; Nori D
    Brachytherapy; 2010; 9(1):76-80. PubMed ID: 19853537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of perigraft seroma in expanded polytetrafluoroethylene grafts by sequential fibrin sealing of the outer graft surface.
    Zanow J; Kruger U; Settmacher U; Scholz H
    Ann Vasc Surg; 2010 Nov; 24(8):1005-14. PubMed ID: 20800429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonographic assessment of polytetrafluoroethylene upper extremity arteriovenous hemodialysis access: a retrospective analysis of 31 cases.
    Ren J; Han X; Liu H; Chen X; Ma N; Tan Q
    Ther Apher Dial; 2012 Dec; 16(6):548-53. PubMed ID: 23190514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection of hemodialysis arteriovenous grafts.
    Akoh JA; Patel N
    J Vasc Access; 2010; 11(2):155-8. PubMed ID: 20175060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.